nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Blood bilirubin abnormal—Riluzole—amyotrophic lateral sclerosis	0.149	0.187	CcSEcCtD
Naratriptan—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.041	0.0517	CcSEcCtD
Naratriptan—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0323	0.157	CbGeAlD
Naratriptan—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.0323	0.0407	CcSEcCtD
Naratriptan—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0313	0.152	CbGeAlD
Naratriptan—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.0289	0.0364	CcSEcCtD
Naratriptan—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0236	0.0297	CcSEcCtD
Naratriptan—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0204	CcSEcCtD
Naratriptan—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0199	CcSEcCtD
Naratriptan—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0194	CcSEcCtD
Naratriptan—MAOA—nerve—amyotrophic lateral sclerosis	0.0122	0.0591	CbGeAlD
Naratriptan—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0151	CcSEcCtD
Naratriptan—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0147	CcSEcCtD
Naratriptan—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.014	CcSEcCtD
Naratriptan—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0139	CcSEcCtD
Naratriptan—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.01	0.0485	CbGeAlD
Naratriptan—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00999	0.0126	CcSEcCtD
Naratriptan—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00992	0.0125	CcSEcCtD
Naratriptan—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0119	CcSEcCtD
Naratriptan—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0119	CcSEcCtD
Naratriptan—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00914	0.0443	CbGeAlD
Naratriptan—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00912	0.0115	CcSEcCtD
Naratriptan—HTR1F—nervous system—amyotrophic lateral sclerosis	0.00909	0.044	CbGeAlD
Naratriptan—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0113	CcSEcCtD
Naratriptan—HTR1F—central nervous system—amyotrophic lateral sclerosis	0.00875	0.0424	CbGeAlD
Naratriptan—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00865	0.0109	CcSEcCtD
Naratriptan—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00865	0.0109	CcSEcCtD
Naratriptan—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0085	0.0107	CcSEcCtD
Naratriptan—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00841	0.0106	CcSEcCtD
Naratriptan—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00933	CcSEcCtD
Naratriptan—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00916	CcSEcCtD
Naratriptan—HTR1B—brainstem—amyotrophic lateral sclerosis	0.0071	0.0344	CbGeAlD
Naratriptan—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00884	CcSEcCtD
Naratriptan—HTR1F—brain—amyotrophic lateral sclerosis	0.00694	0.0337	CbGeAlD
Naratriptan—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00688	0.0333	CbGeAlD
Naratriptan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00686	0.00865	CcSEcCtD
Naratriptan—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00861	CcSEcCtD
Naratriptan—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0085	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00846	CcSEcCtD
Naratriptan—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00645	0.00813	CcSEcCtD
Naratriptan—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00806	CcSEcCtD
Naratriptan—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00762	CcSEcCtD
Naratriptan—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.006	0.00756	CcSEcCtD
Naratriptan—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00725	CcSEcCtD
Naratriptan—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00573	0.0278	CbGeAlD
Naratriptan—MAOA—embryo—amyotrophic lateral sclerosis	0.00572	0.0277	CbGeAlD
Naratriptan—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00708	CcSEcCtD
Naratriptan—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0069	CcSEcCtD
Naratriptan—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0054	0.00681	CcSEcCtD
Naratriptan—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00679	CcSEcCtD
Naratriptan—MAOA—brainstem—amyotrophic lateral sclerosis	0.00524	0.0254	CbGeAlD
Naratriptan—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00654	CcSEcCtD
Naratriptan—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00646	CcSEcCtD
Naratriptan—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00635	CcSEcCtD
Naratriptan—Depression—Riluzole—amyotrophic lateral sclerosis	0.005	0.0063	CcSEcCtD
Naratriptan—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00622	CcSEcCtD
Naratriptan—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00619	CcSEcCtD
Naratriptan—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00619	CcSEcCtD
Naratriptan—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0048	0.00605	CcSEcCtD
Naratriptan—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00592	CcSEcCtD
Naratriptan—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00577	CcSEcCtD
Naratriptan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0057	CcSEcCtD
Naratriptan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00567	CcSEcCtD
Naratriptan—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00564	CcSEcCtD
Naratriptan—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00564	CcSEcCtD
Naratriptan—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00442	0.0214	CbGeAlD
Naratriptan—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00526	CcSEcCtD
Naratriptan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00514	CcSEcCtD
Naratriptan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00512	CcSEcCtD
Naratriptan—Chills—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00509	CcSEcCtD
Naratriptan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00402	0.00506	CcSEcCtD
Naratriptan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00501	CcSEcCtD
Naratriptan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00474	CcSEcCtD
Naratriptan—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00372	0.018	CbGeAlD
Naratriptan—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00462	CcSEcCtD
Naratriptan—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00365	0.0177	CbGeAlD
Naratriptan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00458	CcSEcCtD
Naratriptan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00456	CcSEcCtD
Naratriptan—HTR1D—nervous system—amyotrophic lateral sclerosis	0.0036	0.0175	CbGeAlD
Naratriptan—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00453	CcSEcCtD
Naratriptan—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00358	0.0174	CbGeAlD
Naratriptan—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00356	0.0173	CbGeAlD
Naratriptan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00445	CcSEcCtD
Naratriptan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00443	CcSEcCtD
Naratriptan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00442	CcSEcCtD
Naratriptan—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00347	0.0168	CbGeAlD
Naratriptan—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00436	CcSEcCtD
Naratriptan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00434	CcSEcCtD
Naratriptan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00431	CcSEcCtD
Naratriptan—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00427	CcSEcCtD
Naratriptan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0042	CcSEcCtD
Naratriptan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0042	CcSEcCtD
Naratriptan—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00419	CcSEcCtD
Naratriptan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00415	CcSEcCtD
Naratriptan—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00411	CcSEcCtD
Naratriptan—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00326	0.0158	CbGeAlD
Naratriptan—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00406	CcSEcCtD
Naratriptan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00403	CcSEcCtD
Naratriptan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00403	CcSEcCtD
Naratriptan—Infection—Riluzole—amyotrophic lateral sclerosis	0.00318	0.004	CcSEcCtD
Naratriptan—Shock—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00396	CcSEcCtD
Naratriptan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00395	CcSEcCtD
Naratriptan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00394	CcSEcCtD
Naratriptan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00391	CcSEcCtD
Naratriptan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00389	CcSEcCtD
Naratriptan—HTR1A—nervous system—amyotrophic lateral sclerosis	0.003	0.0146	CbGeAlD
Naratriptan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00376	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00367	CcSEcCtD
Naratriptan—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00289	0.014	CbGeAlD
Naratriptan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00362	CcSEcCtD
Naratriptan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00359	CcSEcCtD
Naratriptan—HTR1B—brain—amyotrophic lateral sclerosis	0.00285	0.0138	CbGeAlD
Naratriptan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00358	CcSEcCtD
Naratriptan—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00283	0.0137	CbGeAlD
Naratriptan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00348	CcSEcCtD
Naratriptan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00347	CcSEcCtD
Naratriptan—HTR1D—brain—amyotrophic lateral sclerosis	0.00275	0.0134	CbGeAlD
Naratriptan—MAOA—nervous system—amyotrophic lateral sclerosis	0.00274	0.0133	CbGeAlD
Naratriptan—Pain—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00344	CcSEcCtD
Naratriptan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00344	CcSEcCtD
Naratriptan—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00264	0.0128	CbGeAlD
Naratriptan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00332	CcSEcCtD
Naratriptan—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00258	0.0125	CbGeAlD
Naratriptan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0032	CcSEcCtD
Naratriptan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00318	CcSEcCtD
Naratriptan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00297	CcSEcCtD
Naratriptan—HTR1A—brain—amyotrophic lateral sclerosis	0.0023	0.0111	CbGeAlD
Naratriptan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00289	CcSEcCtD
Naratriptan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00285	CcSEcCtD
Naratriptan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00276	CcSEcCtD
Naratriptan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00266	CcSEcCtD
Naratriptan—MAOA—brain—amyotrophic lateral sclerosis	0.0021	0.0102	CbGeAlD
Naratriptan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00256	CcSEcCtD
Naratriptan—Rash—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00254	CcSEcCtD
Naratriptan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00254	CcSEcCtD
Naratriptan—Headache—Riluzole—amyotrophic lateral sclerosis	0.002	0.00252	CcSEcCtD
Naratriptan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00239	CcSEcCtD
